In: pharmaceutical research
Recently, open science has been making major strides in the news. Sure, people have been clamoring for full disclosure and availability of journal…
Read MoreComputational drug discovery has reduced the time and money required for research and development while increasing the potential number of drug leads in…
Read MoreThis is the second in a three-part series by Dr. Heather Buschman on Big Data in the pharmaceutical and biotechnology industries. Check out…
Read MoreWith the Big Data Science Innovation Summit 1 happening next month here in San Diego, we invited Dr. Heather Buschman to share current views on Big…
Read MoreRecently, Oxbridge Biotech Roundtable (OBR) interviewed Assay Depot’s Kevin Lustig about how his career decisions and approach to research shaped his view of…
Read More